What is the treatment for Lyme disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Lyme Disease

For early Lyme disease with erythema migrans, treat with oral doxycycline 100 mg twice daily for 10-14 days in adults and children ≥8 years old, or amoxicillin 500 mg three times daily for 14 days in younger children and pregnant patients. 1, 2

Early Localized Disease (Erythema Migrans)

First-Line Oral Regimens

Adults and children ≥8 years:

  • Doxycycline 100 mg twice daily for 10-14 days is the preferred agent 1, 3
  • Doxycycline has the critical advantage of treating concurrent human granulocytic anaplasmosis (HGA), which may coexist in up to 10% of cases 2
  • Patients must avoid sun exposure due to photosensitivity risk and take with 8 ounces of fluid to prevent esophageal irritation 2, 4

Children <8 years and pregnant/lactating patients:

  • Amoxicillin 50 mg/kg/day divided into 3 doses (maximum 500 mg per dose) for 14 days 2
  • Alternative: Cefuroxime axetil 30 mg/kg/day in 2 divided doses (maximum 500 mg per dose) for 14 days 2
  • Doxycycline must be avoided in pregnancy and young children 1

Agents to Avoid

  • First-generation cephalosporins (cephalexin) are completely ineffective and should never be used 1, 2
  • Fluoroquinolones, carbapenems, vancomycin, metronidazole, and azithromycin are not recommended 1
  • Macrolides (azithromycin, clarithromycin) are significantly less effective and should only be used when patients cannot tolerate first-line agents 2

Early Neurologic Disease

Meningitis or Radiculopathy

Parenteral therapy is required:

  • Ceftriaxone 2 g IV once daily (or 50-75 mg/kg/day in children, maximum 2 g) for 14 days (range 10-28 days) 1, 2
  • Alternative: Cefotaxime 2 g IV every 8 hours or penicillin G 18-24 million units/day divided every 4 hours 1

Isolated Cranial Nerve Palsy (Facial Nerve Palsy)

Oral therapy is sufficient if no meningeal signs:

  • Use the same oral regimens as for erythema migrans for 14-21 days 1
  • Lumbar puncture is indicated only if severe headache, nuchal rigidity, or other CNS symptoms are present 1
  • If CSF shows pleocytosis, switch to parenteral therapy as for meningitis 1
  • No recommendation can be made regarding corticosteroid use 1

Lyme Carditis

Outpatient Management

  • Oral antibiotics (doxycycline, amoxicillin, or cefuroxime) for 14-21 days for mild cases 1

Hospitalization Criteria

Admit patients with any of the following:

  • PR interval >300 milliseconds 1
  • Second- or third-degree AV block 1
  • First-degree block with PR ≥300 milliseconds (can rapidly progress) 1
  • Symptomatic bradycardia, syncope, dyspnea, chest pain, or signs of myopericarditis 1

Hospitalized patients:

  • Start with IV ceftriaxone 2 g daily until clinical improvement, then switch to oral antibiotics to complete 14-21 days total 1
  • Continuous cardiac monitoring is mandatory 1
  • Use temporary pacing for symptomatic bradycardia rather than permanent pacemaker 1

Lyme Arthritis

Initial Treatment

  • Oral antibiotics for 28 days (doxycycline, amoxicillin, or cefuroxime) 1
  • Serum antibody testing is preferred over PCR or culture for diagnosis 1

Persistent or Recurrent Arthritis

  • Consider a second 28-day course of oral antibiotics if partial improvement occurred 1
  • If no improvement after oral therapy and synovial fluid PCR is negative, switch to symptomatic treatment with NSAIDs, intra-articular corticosteroids, or DMARDs (hydroxychloroquine) rather than more antibiotics 1
  • Arthroscopic synovectomy may reduce duration of joint inflammation 1

Late Neurologic Disease

For CNS or peripheral nervous system involvement:

  • IV ceftriaxone 2 g daily for 14-28 days 1, 5
  • Alternative: IV cefotaxime or penicillin G 1
  • Response is typically slow and may be incomplete 1

Critical Pitfalls to Avoid

Coinfection Recognition

Consider coinfection with Babesia or Anaplasma if:

  • High fever persists >48 hours despite appropriate Lyme treatment 1
  • Unexplained leukopenia, thrombocytopenia, or anemia present 1
  • Patient more systemically ill than typical for Lyme disease alone 1

Post-Treatment Lyme Disease Syndrome

Do NOT prescribe additional antibiotics for:

  • Persistent nonspecific symptoms (fatigue, pain, cognitive impairment) without objective signs of active infection 1
  • Patients lacking evidence of reinfection or treatment failure 1
  • Prolonged antibiotic therapy has no proven benefit and may cause harm 1, 2

Monitoring Expectations

  • Most patients respond promptly to appropriate therapy 2
  • Complete resolution may be delayed beyond treatment duration—this is normal 1
  • Patients who are more systemically ill at diagnosis may take longer to respond 2
  • Less than 10% fail to respond to initial appropriate therapy 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Children with Borrelia burgdorferi (Lyme Disease)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cephalexin and Photosensitivity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Digital Necrosis in Patients with Raynaud's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.